Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.

Source:http://linkedlifedata.com/resource/pubmed/id/15289356

Cancer Res. 2004 Aug 1 64 15 5461-70

Download in:

View as

General Info

PMID
15289356